Medical Services Increases Contracts in China
May 24 2006 - 1:14PM
PR Newswire (US)
EDMONTON, Alberta, May 24 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (OTC:MSITF) is pleased to announce that
it has increased its contracts in China. The Company is now
supplying 18 separate hospitals in China the VScan HIV test kit.
This is in addition to pharmaceutical companies, a large industrial
company with in excess of 300,000 employees, one retail chain, and
the Company expects to add another retail chain within 60 to 90
days. This group currently using the VScan test kit just represents
the SE China area. The Companies' distributor has started to
introduce the VScan products into northeast China and has been
receiving a very positive response to the VScan test kits. As
reported earlier the existing contracts represents in excess of 25
million US dollars in sales over a three year period. It is
anticipated that the Company will be able to arrange additional
contracts in northeast China that will add a further 3 to 4 million
US dollars in sales from China. About VScan The VScan rapid test
kit is a single use, disposable, accurate, cost effective, easy to
use, test for the screening of HIV 1&2, Hepatitis B&C,
Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria, and
Prostate Cancer. The kits cannot be sold in Canada. Medical
Services International Inc. trades in the United States on the NQB
Pinksheets under the symbol "MSITF". For further information,
please contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright